The Bumpy Road To Approving New Alzheimer's Drugs : vimarsan

After a controversial Alzheimer’s medication was discontinued, a new anti-amyloid drug receives extra scrutiny from the FDA.

Related Keywords

United States , Eli Lilly , Jason Karlawish , Arielle Duhaime Ross , Human Services , University Of Pennsylvania Perelman School Medicine , Department Of Health , Penn Memory Center , Drug Administration , Silver Spring , Oak Campus , United States Food , Perelman School , Penn Memory ,